A randomized, double-blind and placebo-controlled Phase II clinical trial of trigriluzole in patients with mild-to-moderate Alzheimer's Disease

Trial Profile

A randomized, double-blind and placebo-controlled Phase II clinical trial of trigriluzole in patients with mild-to-moderate Alzheimer's Disease

Planning
Phase of Trial: Phase II

Latest Information Update: 19 Sep 2017

At a glance

  • Drugs Trigriluzole (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Sep 2017 New trial record
    • 15 Sep 2017 According to a Biohaven Pharmaceutical Holding Company media release, the company has a clinical trial collaboration with the Alzheimer's Disease Cooperative Study (ADCS) for the condut of this trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top